MAZE

31.3703.27%
JE

Jonathan E. Lim

Independent Non-Employee Director

Dr. Jonathan E. Lim, M.D., is Member of Advisory Board of Independa, Inc. Dr. Lim is Managing Partner and Founder of City Hill Ventures, LLC. Dr. Lim is Co-Founder, Chairman & CEO of Erasca, Inc. from March 2019. Dr. Lim joined the Erasca, Inc. in July 2018. Dr. Lim is Independent Non-Employee Director of Maze Therapeutics, Inc. Dr. Lim was Director of Maze Therapeutics, Inc. from October 2019. Dr. Lim is Co-Founder & Independent Chairman of Boundless Bio, Inc. from December 2018. Dr. Lim was Venture Partner of Arch Venture Partners, L.P. until May 2026. Dr. Lim was employed at Arch Venture Partners, L.P. until May 2026. Dr. Lim focused on Biotechnology, Pharmaceuticals & Entrepreneurship. Dr. Lim was Chief Executive Officer, President and Executive Director of Halozyme Therapeutics, Inc. Dr. Lim was employed at Halozyme Therapeutics, Inc. from May 2003 to December 03, 2010. Dr. Lim was Co-Founder & Chairman of Bonti, Inc. until October 2018. Dr. Lim was employed at Bonti, Inc. until October 2018. Dr. Lim was Co-Founder of Ignyta, Inc. Dr. Lim was employed at Ignyta, Inc. from August 2011 to February 08, 2018. Dr. Lim was Non-Executive Director of Neuphoria Therapeutics Inc. until November 18, 2015. Dr. Lim was employed at Neuphoria Therapeutics Inc. from September 14, 2012 to November 18, 2015. Dr. Lim was Executive Chairman of Eclipse Therapeutics, Inc. Dr. Lim was Chief Executive Officer and President of Global Yacht Services, Inc. From 2001 to 2003, he was a Management Consultant at McKinsey & Company, where he specialized in the health care industry, serving a wide range of start-ups to Fortune 500 companies in the biopharmaceutical, medical products and payer/provider segments. From 1999 to 2001, Dr. Lim was a recipient of a National Institutes of Health Postdoctoral Fellowship, during which time he conducted clinical outcomes research at Harvard Medical School and the Dana-Farber Cancer Institute and several years of general surgery residency at New York Hospital-Cornell and Memorial Sloan Kettering Cancer Center. Dr. Lim has been a member of the Board of Overseers at Scripps Research since October 2018, a member of the Board of Visitors of the Moores Cancer Center at the University of California, San Diego since 2015 and a member of the Stanford Interdisciplinary Biosciences Council since 2014. His prior experience also includes several years Founding Editor-in-Chief of the McGill Journal of Medicine; and basic science and clinical research at the Salk Institute for Biological Studies and Massachusetts Eye and Ear Infirmary. Dr. Lim has published articles in leading peer-reviewed medical journals such as the Annals of Surgery and the Journal of Refractive Surgery. Dr. Lim has M.P.H in Healthcare Administration from Harvard University, B.S. in Biological Sciences from Stanford University, M.S. in Biological Sciences from Stanford University and M.D. from McGill University.

Positions